Severe inflammation and reduced bacteria load in murine Helicobacter infection caused by lack of phagocyte oxidase activity

被引:48
作者
Blanchard, TG
Yu, FW
Hsieh, CL
Redline, RW
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
关键词
D O I
10.1086/374780
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The vaccine-induced immune mechanisms that protect against Helicobacter pylori infection in the mouse model have not been identified. This study investigated the contribution of reactive oxygen and nitrogen intermediates to Helicobacter pathogenesis and immunity. Mice deficient in nicotinamide-adenine dinucleotide phosphate oxidase activity (gp91(phox-/-)), nitric oxide synthase activity (NOS2(-/-)), or both (gp91(phox-/-)/ NOS2(-/-)) were infected with Helicobacter organisms and evaluated for inflammation and bacteria load. Infection of all 3 transgenic strains resulted in significantly more inflammation than found in infected C57BL/6 wild-type mice. However, only gp91(phox-/-) and gp91(phox-/-)/NOS2(-/-) mice had significantly reduced numbers of infected gastric glands. Intranasal immunization of NOS2(-/-) or gp91(phox-/-)/NOS2(-/-) mice against H. pylori resulted in protective immunity comparable to that seen in C57BL/6 control mice. Therefore, reactive oxygen species may play a role in limiting the inflammatory response associated with H. pylori infection of the gastric mucosa but may also limit the host's ability to eradicate Helicobacter organisms.
引用
收藏
页码:1609 / 1615
页数:7
相关论文
共 40 条
  • [21] A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
    Lee, A
    ORourke, J
    DeUngria, MC
    Robertson, B
    Daskalopoulos, G
    Dixon, MF
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : 1386 - 1397
  • [22] ORAL IMMUNIZATION WITH RECOMBINANT HELICOBACTER-PYLORI UREASE INDUCES SECRETORY IGA ANTIBODIES AND PROTECTS MICE FROM CHALLENGE WITH HELICOBACTER-FELIS
    LEE, CK
    WELTZIN, R
    THOMAS, WD
    KLEANTHOUS, H
    ERMAK, TH
    SOMAN, G
    HILL, JE
    ACKERMAN, SK
    MONATH, TP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) : 161 - 172
  • [23] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [24] Mannick EE, 1996, CANCER RES, V56, P3238
  • [25] DEVELOPMENT OF A MOUSE MODEL OF HELICOBACTER-PYLORI INFECTION THAT MIMICS HUMAN-DISEASE
    MARCHETTI, M
    ARICO, B
    BURRONI, D
    FIGURA, N
    RAPPUOLI, R
    GHIARA, P
    [J]. SCIENCE, 1995, 267 (5204) : 1655 - 1658
  • [26] IMMUNIZATION OF BALB/C MICE AGAINST HELICOBACTER-FELIS INFECTION WITH HELICOBACTER-PYLORI UREASE
    MICHETTI, P
    CORTHESYTHEULAZ, I
    DAVIN, C
    HAAS, R
    VANEY, AC
    HEITZ, M
    BILLE, J
    KRAEHENBUHL, JP
    SARAGA, E
    BLUM, AL
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1002 - 1011
  • [27] Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
    Michetti, P
    Kreiss, C
    Kotloff, KL
    Porta, N
    Blanco, JL
    Bachmann, D
    Herranz, M
    Saldinger, PF
    Corthésy-Theulaz, I
    Losonsky, G
    Nichols, R
    Simon, J
    Stolte, M
    Ackerman, S
    Monath, TP
    Blum, AL
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : 804 - 812
  • [28] Inducible nitric oxide synthase: What difference does it make?
    Nathan, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) : 2417 - 2423
  • [29] Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
    Pappo, J
    Torrey, D
    Castriotta, L
    Savinainen, A
    Kabok, Z
    Ibraghimov, A
    [J]. INFECTION AND IMMUNITY, 1999, 67 (01) : 337 - 341
  • [30] HELICOBACTER-PYLORI INFECTION IN INTESTINAL-TYPE AND DIFFUSE-TYPE GASTRIC ADENOCARCINOMAS
    PARSONNET, J
    VANDERSTEEN, D
    GOATES, J
    SIBLEY, RK
    PRITIKIN, J
    CHANG, Y
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (09): : 640 - 643